If you’re like many pharmaceutical and functional food executives I speak with…
…then expanding distribution of your products across the globe is a highly desirable
goal. Yet it is also an onerous task – time-consuming, complex, and fraught with pitfalls.
At Cetalus, our focus is helping companies such as yours, with winning human and
animal health products market them and secure licensees and distributors amongst
leading companies in major countries where they are not currently sold.
We do this through our network of decision making executives – in over 2000
companies in 50 countries worldwide. Companies that are decisive with new product
For instance, we recently enabled a leading functional food company to license their
product to the top direct marketer in that space … and the product now ranks #1 in its
The Business Development project leader of a leading North American pharmaceutical
company wrote of CETALUS, “I am not sure that I have ever worked with a consultancy
that is so good at focused listening and at finding common ground in order to elicit co-
operation from both parties to an agreement.”
Our triple-pronged approach for product licensing combines CEO-level strategic thinking
and hands-on business development with world-class project management – a winning
formula for opening new markets for pharmaceutical and functional food products with
If you have such a winning product, please call us at +1 786 899 5100 or email me directly
at email@example.com – or click here for a no-cost, no-obligation conference call
to explore your product’s potential for licensing and expanding into new markets – and
by doing so, dramatically improving your market share, sales, and profitability.
Ajay Srinivas, President and CEO
President and CEO, Cetalus LLC
We accept assignments where we believe we can provide superior, practical and transformational benefits for the Principal – Licensor, Discover. Manufacturer and their Clients - Licensee, Marketer, Distributor on a sustainable basis, for example, securing a leading position in a key therapeutic group such as Diabetes or Immune Modulation.